Commentary : CD6 As a Potential Target for Treating Multiple Sclerosis
| Errataetall: |
CommentOn: Proc Natl Acad Sci U S A. 2017 Mar 7;114(10 ):2687-2692. - PMID 28209777 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Frontiers in immunology - 8(2017) vom: 02., Seite 1217 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Consuegra-Fernández, Marta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CD6 |
|---|
| Anmerkungen: |
Date Revised 24.09.2021 published: Electronic-eCollection CommentOn: Proc Natl Acad Sci U S A. 2017 Mar 7;114(10 ):2687-2692. - PMID 28209777 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fimmu.2017.01217 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM27702711X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM27702711X | ||
| 003 | DE-627 | ||
| 005 | 20231226194406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2017.01217 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0923.xml |
| 035 | |a (DE-627)NLM27702711X | ||
| 035 | |a (NLM)29033937 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Consuegra-Fernández, Marta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Commentary |b CD6 As a Potential Target for Treating Multiple Sclerosis |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.09.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a CommentOn: Proc Natl Acad Sci U S A. 2017 Mar 7;114(10 ):2687-2692. - PMID 28209777 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a CD6 | |
| 650 | 4 | |a UMCD6 | |
| 650 | 4 | |a cGvHD-induced lupus-like disease | |
| 650 | 4 | |a collagen-induced arthritis | |
| 650 | 4 | |a experimental autoimmune encephalomyelitis | |
| 650 | 4 | |a itolizumab | |
| 650 | 4 | |a multiple sclerosis | |
| 700 | 1 | |a Isamat, Marcos |e verfasserin |4 aut | |
| 700 | 1 | |a Lozano, Francisco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 8(2017) vom: 02., Seite 1217 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2017 |g day:02 |g pages:1217 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2017.01217 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2017 |b 02 |h 1217 | ||